Comments: While high-sensitivity cardiac troponin assays are yet to be US Food and Drug Administration—approved, growing data around the world, including studies such as this, seem to suggest that it is a useful tool in risk-stratifying patients with chest pain presenting to the emergency department. This large retrospective study demonstrates great efficacy in ruling out myocardial infarction when paired with an electrocardiogram not concerning for ischemia; more data may help guide the utility of these new assays as their popularity grows.
展开▼